Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
Pharm Biol ; 59(1): 401-409, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33794116

ABSTRACT

CONTEXT: Pomelo peel oil (PPO) [Citrus maxima (Burm.) Merr. (Rutaceae)] is reported to possess antioxidant and antimelanogenic activities. OBJECTIVE: To investigate the effect of PPO [Citrus maxima (Burm.) Merr. cv. Shatian Yu] on tumour necrosis factor-α (TNF-α)-induced necroptosis in cerebral ischaemia-reperfusion injury (CIRI) after cardiac arrest (CA). MATERIALS AND METHODS: Male Sprague Dawley rats were randomly assigned to six groups: sham group, PP0-L (10 mg/kg), PPO-M (20 mg/kg), PPO-H (40 mg/kg) and two control groups (CA, 0.9% saline; Gly, 10% glycerol). All drugs were administered intravenously to the CA/CPR rats within 10 min after return of spontaneous circulation (ROSC). After 24 h, rats were assessed for neuronal injury via the neurological deficit score (NDS), cerebral cortex staining and transmission electron microscopy (TEM) and expression levels of TNF-α and necroptosis-related proteins by immunoreactivity staining and western blotting. RESULTS: Compared to those in the sham group (survival rate, 100% and NDS, 80), the survival rate and NDS were significantly reduced in the model groups (CA, 56.25%, 70; Gly, 62.5%, 71; PPO-L, 75%, 72; PPO-M, 87.5%, 75; PPO-H, 81.25%, 74). In the PPO-M group, Nissl bodies were significantly increased (43.67 ± 1.906 vs. 17 ± 1.732), the incidence of pathomorphological injury was lower and the necroptosis markers (TNF-α, RIPK1, RIPK3, p-MLKL/MLKL) expression was downregulated compared to those in the CA group (p < 0.05). DISCUSSION AND CONCLUSIONS: The neuroprotective effects of PPO in the CA rats suggested that PPO possibility as a health product enhances the resistance ability against brain injury for humans.


Subject(s)
Citrus/chemistry , Heart Arrest/drug therapy , Plant Oils/pharmacology , Reperfusion Injury/drug therapy , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Heart Arrest/physiopathology , Male , Necroptosis/drug effects , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/isolation & purification , Neuroprotective Agents/pharmacology , Oils, Volatile/administration & dosage , Oils, Volatile/isolation & purification , Oils, Volatile/pharmacology , Plant Oils/administration & dosage , Plant Oils/isolation & purification , Random Allocation , Rats , Rats, Sprague-Dawley , Reperfusion Injury/physiopathology , Survival Rate , Tumor Necrosis Factor-alpha/administration & dosage
2.
Expert Opin Ther Targets ; 24(3): 267-279, 2020 03.
Article in English | MEDLINE | ID: mdl-32077781

ABSTRACT

Objectives: 10-hydroxydec-2-enoic acid (10-HDA), a unique component of royal jelly existing only in nature, has the potential to promote human health. Knowledge of 10-HDA in regulating immuno-activity, however, is lacking. The aim of our work is to gain a novel understanding of 10-HDA in promoting immunity.Methods: Immuno-suppressed mice were generated by cyclophosphamide injection, After 10-HDA supplementation to the mice to rescue their immunity, the proteomes of the thymus and spleen were analyzed.Results: The weight of the body, thymus, and spleen in cyclophosphamide-induced mice recovered by 10-HDA indicate its potential role in immuno-organ protection. In the thymus, the enhanced activity of pathways associated with DNA/RNA/protein activities may be critical for T-lymphocyte proliferation/differentiation, and cytotoxicity. In the spleen, the induced pathways involved in DNA/RNA/protein activities, and cell proliferative stimulation suggest their vital role in B-lymphocyte affinity maturation, antigen presentation, and macrophage activity. The up-regulated proteins highly connected in networks modulated by 10-HDA indicate that the mice may evolve tactics to respond to immuno-organ impairment by activating critical physiological processes.Conclusion: Our data constitute a proof-of-concept that 10-HDA is a potential agent to improve immunity in the thymus and spleen and offer a new venue for applying natural products to the therapy for hypoimmunity.


Subject(s)
Fatty Acids, Monounsaturated/pharmacology , Proteome/immunology , Spleen/drug effects , Thymus Gland/drug effects , Animals , Cell Proliferation/drug effects , Cyclophosphamide/pharmacology , Fatty Acids/chemistry , Fatty Acids, Monounsaturated/isolation & purification , Female , Immunosuppressive Agents/immunology , Male , Mice , Mice, Inbred BALB C , Spleen/immunology , T-Lymphocytes/immunology , Thymus Gland/immunology
SELECTION OF CITATIONS
SEARCH DETAIL